Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Big Data

Sec. Medicine and Public Health

This article is part of the Research TopicArtificial Intelligence and Medical Image ProcessingView all articles

Implementation of a Net Benefit Parameter in ROC Curve Decision Thresholds for AI-Powered Mammography Screening

Provisionally accepted
Anastasia  Petrovna PamovaAnastasia Petrovna Pamova1*Yuriy  Aleksandrovich VasilevYuriy Aleksandrovich Vasilev1,2Tatyana  Mikhaylovna BobrovskayaTatyana Mikhaylovna Bobrovskaya1*Anton  Vyacheslavovich VladzimirskyyAnton Vyacheslavovich Vladzimirskyy1,3Olga  Vasilyevna OmelyanskayaOlga Vasilyevna Omelyanskaya1Kirill  Mikhailovich ArzamasovKirill Mikhailovich Arzamasov1,4
  • 1Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
  • 2FGBU Nacional'nyj mediko-hirurgiceskij Centr imeni N I Pirogova Ministerstva zdravoohranenia Rossijskoj Federacii, Moscow, Russia
  • 3I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moccow, Russia
  • 4MIREA Rossijskij tehnologiceskij universitet Institut informacionnyh tehnologij, Moscow, Russia

The final, formatted version of the article will be published soon.

Background: The rapid integration of artificial intelligence (AI) into mammography necessitates robust quality control methods. The lack of standardized methods for establishing decision thresholds on the Receiver Operating Characteristic (ROC) curves makes it challenging to judge the AI performance. This study aims to develop a method for deter-mining the decision threshold for AI in screening mammography to ensure the widest possible population of women with a breast pathology is diagnosed.Methods: Three AI models were retrospectively evaluated using a dataset of digital mammograms. The dataset consisted of screening mammography examinations obtained from 663,606 patients over the age of 40. Our method estimates the decision threshold using a novel approach to net benefit (NB) analysis. Our approach to setting the cutoff threshold was compared with the threshold determined by Youden's index using McNemar's test.Results: Replacing the Youden index with our method across three AI models, resulted in a threefold reduction in false-positive rates, twofold reduction in false-negative rates, and twofold increase in true-positive rates. Thus, the sensitivity at the cutoff threshold determined by NB increased to 99% (maximum) compared to the sensitivity determined by Youden's index threshold (72% maximum). Correspondingly, the specificity when using our method decreased to 48% (minimum), compared to 75% (minimum) with the Youden's index method.Conclusions: We propose using AI as the initial reader together with our novel method for determining the decision threshold in screening with double reading. This approach enhances the AI sensitivity and improves timely breast cancer diagnosis. This study was registered in ClinicalTrials (NCT04489992) (https://clinicaltrials.gov/study/NCT04489992).

Keywords: медицинская помощь, здоровье населения, искусственный интеллект, экранирование, машинное обучение, маммография

Received: 22 Aug 2025; Accepted: 24 Oct 2025.

Copyright: © 2025 Pamova, Vasilev, Bobrovskaya, Vladzimirskyy, Omelyanskaya and Arzamasov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Anastasia Petrovna Pamova, pamovaap@zdrav.mos.ru
Tatyana Mikhaylovna Bobrovskaya, bobrovskayatm@zdrav.mos.ru

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.